{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:29:34Z","timestamp":1772119774660,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s11033-022-07235-1","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T15:04:55Z","timestamp":1647529495000},"page":"3875-3883","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A new approach to sepsis treatment by rasagiline: a molecular, biochemical and histopathological study"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1772-282X","authenticated-orcid":false,"given":"Harun","family":"Un","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rustem Anil","family":"Ugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duygu","family":"Kose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed","family":"Yayla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tugba Bal","family":"Tastan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasin","family":"Bayir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zekai","family":"Halici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"key":"7235_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"7235_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.immuni.2014.04.001","volume":"40","author":"CS Deutschman","year":"2014","unstructured":"Deutschman CS, Tracey KJ (2014) Sepsis: current dogma and new perspectives. Immunity 40:463\u2013475. https:\/\/doi.org\/10.1016\/j.immuni.2014.04.001","journal-title":"Immunity"},{"key":"7235_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1164\/rccm.201904-0910LE","volume":"201","author":"EF Carlton","year":"2020","unstructured":"Carlton EF, McHugh WM, McDonough K, Sturza J, Desch K, Cornell TT (2020) Markers of Endothelial Dysfunction and Cytokines in High-Risk Pediatric Patients with Severe Sepsis. Am J Respir Crit Care Med 201:380\u2013384. https:\/\/doi.org\/10.1164\/rccm.201904-0910LE","journal-title":"Am J Respir Crit Care Med"},{"key":"7235_CR4","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41419-019-2015-1","volume":"10","author":"C Cao","year":"2019","unstructured":"Cao C, Yu M, Chai Y (2019) Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis. Cell Death Dis 10:782. https:\/\/doi.org\/10.1038\/s41419-019-2015-1","journal-title":"Cell Death Dis"},{"key":"7235_CR5","doi-asserted-by":"publisher","first-page":"165974","DOI":"10.1155\/2013\/165974","volume":"2013","author":"W Schulte","year":"2013","unstructured":"Schulte W, Bernhagen J, Bucala R (2013) Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm 2013:165974. https:\/\/doi.org\/10.1155\/2013\/165974","journal-title":"Mediators Inflamm"},{"key":"7235_CR6","first-page":"97","volume":"46","author":"HZ Movat","year":"1987","unstructured":"Movat HZ, Cybulsky MI, Colditz IG, Chan MK, Dinarello CA (1987) Acute inflammation in gram-negative infection: endotoxin, interleukin 1, tumor necrosis factor, and neutrophils. Fed Proc 46:97\u2013104","journal-title":"Fed Proc"},{"key":"7235_CR7","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","volume":"44","author":"MM Levy","year":"2018","unstructured":"Levy MM, Evans LE, Rhodes A (2018) The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med 44:925\u2013928. https:\/\/doi.org\/10.1007\/s00134-018-5085-0","journal-title":"Intensive Care Med"},{"key":"7235_CR8","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2165\/00003495-200767120-00006","volume":"67","author":"V Oldfield","year":"2007","unstructured":"Oldfield V, Keating GM, Perry CM (2007) Rasagiline: a review of its use in the management of Parkinson\u2019s disease. Drugs 67:1725\u20131747. https:\/\/doi.org\/10.2165\/00003495-200767120-00006","journal-title":"Drugs"},{"key":"7235_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/IJG.0b013e3181e3d101","volume":"20","author":"H Levkovitch-Verbin","year":"2011","unstructured":"Levkovitch-Verbin H, Vander S, Melamed S (2011) Rasagiline-induced delay of retinal ganglion cell death in experimental glaucoma in rats. J Glaucoma 20:273\u2013277. https:\/\/doi.org\/10.1097\/IJG.0b013e3181e3d101","journal-title":"J Glaucoma"},{"key":"7235_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/IAE.0b013e31821e2070","volume":"32","author":"S Eigeldinger-Berthou","year":"2012","unstructured":"Eigeldinger-Berthou S, Meier C, Zulliger R, Lecaude S, Enzmann V, Sarra GM (2012) Rasagiline interferes with neurodegeneration in the Prph2\/rds mouse. Retina 32:617\u2013628. https:\/\/doi.org\/10.1097\/IAE.0b013e31821e2070","journal-title":"Retina"},{"key":"7235_CR11","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/mds.23926","volume":"26","author":"P Jenner","year":"2011","unstructured":"Jenner P, Langston JW (2011) Explaining ADAGIO: a critical review of the biological basis for the clinical effects of rasagiline. Mov Disord 26:2316\u20132323. https:\/\/doi.org\/10.1002\/mds.23926","journal-title":"Mov Disord"},{"key":"7235_CR12","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1586\/ern.09.68","volume":"9","author":"M Naoi","year":"2009","unstructured":"Naoi M, Maruyama W (2009) Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson\u2019s disease. Expert Rev Neurother 9:1233\u20131250. https:\/\/doi.org\/10.1586\/ern.09.68","journal-title":"Expert Rev Neurother"},{"key":"7235_CR13","doi-asserted-by":"publisher","unstructured":"Kranthi K, Punnagai VVMAPK, Chellathai D David (2019) A Comparative free Radical Scavenging Evaluation of Amantadine and Rasagiline. Biomedical and Pharmacology Journal. https:\/\/doi.org\/10.13005\/bpj\/1746","DOI":"10.13005\/bpj\/1746"},{"key":"7235_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ehf2.12140","volume":"4","author":"A Varela","year":"2017","unstructured":"Varela A, Mavroidis M, Katsimpoulas M, Sfiroera I, Kappa N, Mesa A, Kostomitsopoulos NG, Cokkinos DV (2017) The neuroprotective agent Rasagiline mesylate attenuates cardiac remodeling after experimental myocardial infarction. ESC Heart Fail 4:331\u2013340. https:\/\/doi.org\/10.1002\/ehf2.12140","journal-title":"ESC Heart Fail"},{"key":"7235_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0441-8","author":"R Sanchez-Rodriguez","year":"2020","unstructured":"Sanchez-Rodriguez R, Munari F, Angioni R, Venegas F, Agnellini A, Castro-Gil MP, Castegna A, Luisetto R, Viola A, Canton M (2020) Targeting monoamine oxidase to dampen NLRP3 inflammasome activation in inflammation. Cell Mol Immunol. https:\/\/doi.org\/10.1038\/s41423-020-0441-8","journal-title":"Cell Mol Immunol"},{"key":"7235_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5152\/eurasianjmed.2017.17062","volume":"49","author":"G Polat","year":"2017","unstructured":"Polat G, Ugan RA, Cadirci E, Halici Z (2017) Sepsis and Septic Shock: Current Treatment Strategies and New Approaches. Eurasian J Med 49:53\u201358. https:\/\/doi.org\/10.5152\/eurasianjmed.2017.17062","journal-title":"Eurasian J Med"},{"key":"7235_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.brainres.2008.11.097","volume":"1256","author":"S Eliash","year":"2009","unstructured":"Eliash S, Dror V, Cohen S, Rehavi M (2009) Neuroprotection by rasagiline in thiamine deficient rats. Brain Res 1256:138\u2013148. https:\/\/doi.org\/10.1016\/j.brainres.2008.11.097","journal-title":"Brain Res"},{"key":"7235_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ejphar.2017.11.011","volume":"818","author":"RA Ugan","year":"2018","unstructured":"Ugan RA, Cadirci E, Halici Z, Toktay E, Cinar I (2018) The role of urotensin-II and its receptors in sepsis-induced lung injury under diabetic conditions. Eur J Pharmacol 818:457\u2013469. https:\/\/doi.org\/10.1016\/j.ejphar.2017.11.011","journal-title":"Eur J Pharmacol"},{"key":"7235_CR19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00210-014-1014-0","volume":"387","author":"E Akpinar","year":"2014","unstructured":"Akpinar E, Halici Z, Cadirci E, Bayir Y, Karakus E, Calik M, Topcu A, Polat B (2014) What is the role of renin inhibition during rat septic conditions: preventive effect of aliskiren on sepsis-induced lung injury. Naunyn Schmiedebergs Arch Pharmacol 387:969\u2013978. https:\/\/doi.org\/10.1007\/s00210-014-1014-0","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"7235_CR20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3109\/08860221003759478","volume":"32","author":"A Uyanik","year":"2010","unstructured":"Uyanik A, Unal D, Uyanik MH, Halici Z, Odabasoglu F, Altunkaynak ZB, Cadirci E, Keles M, Gundogdu C, Suleyman H, Bayir Y, Albayrak M, Unal B (2010) The effects of polymicrobial sepsis with diabetes mellitus on kidney tissues in ovariectomized rats. Ren Fail 32:592\u2013602. https:\/\/doi.org\/10.3109\/08860221003759478","journal-title":"Ren Fail"},{"key":"7235_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/clinchem\/34.3.497","volume":"34","author":"Y Sun","year":"1988","unstructured":"Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497\u2013500","journal-title":"Clin Chem"},{"key":"7235_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","volume":"25","author":"J Sedlak","year":"1968","unstructured":"Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman\u2019s reagent. Anal Biochem 25:192\u2013205. https:\/\/doi.org\/10.1016\/0003-2697(68)90092-4","journal-title":"Anal Biochem"},{"key":"7235_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358. https:\/\/doi.org\/10.1016\/0003-2697(79)90738-3","journal-title":"Anal Biochem"},{"key":"7235_CR24","doi-asserted-by":"crossref","unstructured":"Bayir Y, Un H, Cadirci E, Akpinar E, Diyarbakir B, Calik I, Halici Z (2019) Effects of Aliskiren, an RAAS inhibitor, on a carrageenan-induced pleurisy model of rats. Anais da Academia Brasileira de Ci\u00eancias 91","DOI":"10.1590\/0001-3765201820180106"},{"key":"7235_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/bcpt.12318","volume":"116","author":"R Demir","year":"2015","unstructured":"Demir R, Cadirci E, Akpinar E, Cayir Y, Atmaca HT, Un H, Kunak CS, Yayla M, Bayraktutan Z, Demir I (2015) Does bosentan protect diabetic brain alterations in rats? The role of endothelin-1 in the diabetic brain. Basic Clin Pharmacol Toxicol 116:236\u2013243","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"7235_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2 \u2013 \u2206\u2206CT method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"7235_CR27","first-page":"1262","volume":"21","author":"M Yayla","year":"2018","unstructured":"Yayla M, Cetin D, Adali Y, Kilicle PA, Toktay E (2018) Potential therapeutic effect of pomegranate seed oil on ovarian ischemia\/reperfusion injury in rats. Iran J basic Med Sci 21:1262","journal-title":"Iran J basic Med Sci"},{"key":"7235_CR28","doi-asserted-by":"publisher","first-page":"173168","DOI":"10.1016\/j.ejphar.2020.173168","volume":"880","author":"H Un","year":"2020","unstructured":"Un H, Ugan RA, Kose D, Bayir Y, Cadirci E, Selli J, Halici Z (2020) A novel effect of Aprepitant: Protection for cisplatin-induced nephrotoxicity and hepatotoxicity. Eur J Pharmacol 880:173168","journal-title":"Eur J Pharmacol"},{"key":"7235_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJM198709103171101","volume":"317","author":"RC Bone","year":"1987","unstructured":"Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653\u2013658. https:\/\/doi.org\/10.1056\/NEJM198709103171101","journal-title":"N Engl J Med"},{"key":"7235_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJM199102143240701","volume":"324","author":"EJ Ziegler","year":"1991","unstructured":"Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NN et al (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 324:429\u2013436. https:\/\/doi.org\/10.1056\/NEJM199102143240701","journal-title":"N Engl J Med"},{"key":"7235_CR31","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1056\/NEJM199606273342603","volume":"334","author":"CJ Fisher Jr","year":"1996","unstructured":"Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E (1996) Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 334:1697\u20131702. https:\/\/doi.org\/10.1056\/NEJM199606273342603","journal-title":"N Engl J Med"},{"key":"7235_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00003246-199401000-00008","volume":"22","author":"CJ Fisher Jr","year":"1994","unstructured":"Fisher CJ Jr, Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, Ng D, Bloedow DC, Catalano MA, I.-R, .S.S.S. Group (1994) Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med 22:12\u201321. https:\/\/doi.org\/10.1097\/00003246-199401000-00008","journal-title":"Crit Care Med"},{"key":"7235_CR33","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1097\/CCM.0b013e3182535aeb","volume":"40","author":"M Gao","year":"2012","unstructured":"Gao M, Ha T, Zhang X, Liu L, Wang X, Kelley J, Singh K, Kao R, Gao X, Williams D, Li C (2012) Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis. Crit Care Med 40:2390\u20132399. https:\/\/doi.org\/10.1097\/CCM.0b013e3182535aeb","journal-title":"Crit Care Med"},{"key":"7235_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499\u2013511. https:\/\/doi.org\/10.1038\/nri1391","journal-title":"Nat Rev Immunol"},{"key":"7235_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.neuint.2003.08.005","volume":"44","author":"W Maruyama","year":"2004","unstructured":"Maruyama W, Nitta A, Shamoto-Nagai M, Hirata Y, Akao Y, Yodim M, Furukawa S, Nabeshima T, Naoi M (2004) N-Propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-kappaB transcription factor. Neurochem Int 44:393\u2013400. https:\/\/doi.org\/10.1016\/j.neuint.2003.08.005","journal-title":"Neurochem Int"},{"key":"7235_CR36","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/bjs.1800810914","volume":"81","author":"RT Patel","year":"1994","unstructured":"Patel RT, Deen KI, Youngs D, Warwick J, Keighley MR (1994) Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 81:1306\u20131308. https:\/\/doi.org\/10.1002\/bjs.1800810914","journal-title":"Br J Surg"},{"key":"7235_CR37","doi-asserted-by":"publisher","first-page":"771","DOI":"10.7326\/0003-4819-119-8-199310150-00001","volume":"119","author":"LC Casey","year":"1993","unstructured":"Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771\u2013778. https:\/\/doi.org\/10.7326\/0003-4819-119-8-199310150-00001","journal-title":"Ann Intern Med"},{"key":"7235_CR38","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/jnc.12633","volume":"129","author":"D Trudler","year":"2014","unstructured":"Trudler D, Weinreb O, Mandel SA, Youdim MB, Frenkel D (2014) DJ-1 deficiency triggers microglia sensitivity to dopamine toward a pro-inflammatory phenotype that is attenuated by rasagiline. J Neurochem 129:434\u2013447. https:\/\/doi.org\/10.1111\/jnc.12633","journal-title":"J Neurochem"},{"key":"7235_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1517\/14728222.2014.863876","volume":"18","author":"H Wang","year":"2014","unstructured":"Wang H, Ward MF, Sama AE (2014) Targeting HMGB1 in the treatment of sepsis. Expert Opin Ther Targets 18:257\u2013268. https:\/\/doi.org\/10.1517\/14728222.2014.863876","journal-title":"Expert Opin Ther Targets"},{"key":"7235_CR40","doi-asserted-by":"publisher","first-page":"C441","DOI":"10.1152\/ajpcell.2001.280.3.C441","volume":"280","author":"ED Chan","year":"2001","unstructured":"Chan ED, Riches DW (2001) IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK\/SAPK, and p38(mapk) in a mouse macrophage cell line. Am J Physiol Cell Physiol 280:C441\u2013C450. https:\/\/doi.org\/10.1152\/ajpcell.2001.280.3.C441","journal-title":"Am J Physiol Cell Physiol"},{"key":"7235_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0014-5793(03)01027-5","volume":"553","author":"B Degryse","year":"2003","unstructured":"Degryse B, de Virgilio M (2003) The nuclear protein HMGB1, a new kind of chemokine? FEBS Lett 553:11\u201317. https:\/\/doi.org\/10.1016\/s0014-5793(03)01027-5","journal-title":"FEBS Lett"},{"key":"7235_CR42","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19:477\u2013489. https:\/\/doi.org\/10.1038\/s41577-019-0165-0","journal-title":"Nat Rev Immunol"},{"key":"7235_CR43","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1097\/00003246-199610000-00008","volume":"24","author":"HF Galley","year":"1996","unstructured":"Galley HF, Davies MJ, Webster NR (1996) Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med 24:1649\u20131653. https:\/\/doi.org\/10.1097\/00003246-199610000-00008","journal-title":"Crit Care Med"},{"key":"7235_CR44","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00003246-199603000-00006","volume":"24","author":"E Borrelli","year":"1996","unstructured":"Borrelli E, Roux-Lombard P, Grau GE, Girardin E, Ricou B, Dayer J, Suter PM (1996) Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 24:392\u2013397. https:\/\/doi.org\/10.1097\/00003246-199603000-00006","journal-title":"Crit Care Med"},{"key":"7235_CR45","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1128\/iai.68.4.1942-1945.2000","volume":"68","author":"F Arnalich","year":"2000","unstructured":"Arnalich F, Garcia-Palomero E, Lopez J, Jimenez M, Madero R, Renart J, Vazquez JJ, Montiel C (2000) Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun 68:1942\u20131945. https:\/\/doi.org\/10.1128\/iai.68.4.1942-1945.2000","journal-title":"Infect Immun"},{"key":"7235_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2008.05.013","volume":"29","author":"H Kazama","year":"2008","unstructured":"Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA (2008) Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29:21\u201332. https:\/\/doi.org\/10.1016\/j.immuni.2008.05.013","journal-title":"Immunity"},{"key":"7235_CR47","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/s0024-3205(00)00643-3","volume":"67","author":"MC Carrillo","year":"2000","unstructured":"Carrillo MC, Minami C, Kitani K, Maruyama W, Ohashi K, Yamamoto T, Naoi M, Kanai S, Youdim MB (2000) Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat. Life Sci 67:577\u2013585. https:\/\/doi.org\/10.1016\/s0024-3205(00)00643-3","journal-title":"Life Sci"},{"key":"7235_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2253-10-22","volume":"10","author":"M Weiss","year":"2010","unstructured":"Weiss M, Huber-Lang M, Taenzer M, Kron M, Hay B, Nass M, Huber M, Schneider M (2010) How many general and inflammatory variables need to be fulfilled when defining sepsis due to the 2003 SCCM\/ESICM\/ACCP\/ATS\/SIS definitions in critically ill surgical patients: a retrospective observational study. BMC Anesthesiol 10:22. https:\/\/doi.org\/10.1186\/1471-2253-10-22","journal-title":"BMC Anesthesiol"},{"key":"7235_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1001\/jama.1997.03550030074038","volume":"278","author":"KE Sands","year":"1997","unstructured":"Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR, Black E, Schwartz JS, Moore R, Johnson BL Jr, Platt R, Academic Medical Center Consortium Sepsis Project Working (1997) Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278:234\u2013240","journal-title":"JAMA"},{"key":"7235_CR50","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1097\/SHK.0000000000001393","volume":"53","author":"B Jude","year":"2020","unstructured":"Jude B, Tissier F, Dubourg A, Droguet M, Castel T, Leon K, Giroux-Metges MA, Pennec JP (2020) TGF-beta Pathway Inhibition Protects the Diaphragm From Sepsis-Induced Wasting and Weakness in Rat. Shock 53:772\u2013778. https:\/\/doi.org\/10.1097\/SHK.0000000000001393","journal-title":"Shock"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07235-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07235-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07235-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T16:27:10Z","timestamp":1654619230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07235-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["7235"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07235-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-484375\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,17]]},"assertion":[{"value":"18 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by and performed in accordance with the institutional animal care and use ethics committee of Ataturk University with the protocol number <b>2019-6\/98<\/b>.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}